Literature DB >> 27231460

Targeting the Farnesoid X Receptor in Patients With Cholestatic Liver Disease.

Cynthia Levy1.   

Abstract

Entities:  

Year:  2016        PMID： 27231460      PMCID： PMC4872859     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

Review 1.  New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.

Authors:  Ulrich Beuers; Michael Trauner; Peter Jansen; Raoul Poupon
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 2.  Recent advances in the development of farnesoid X receptor agonists.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Ann Transl Med       Date:  2015-01

Review 3.  FXR: a target for cholestatic syndromes?

Authors:  Shi-Ying Cai; James L Boyer
Journal:  Expert Opin Ther Targets       Date:  2006-06       Impact factor: 6.902

Review 4.  Nuclear receptors as drug targets in cholestatic liver diseases.

Authors:  Emina Halilbasic; Anna Baghdasaryan; Michael Trauner
Journal:  Clin Liver Dis       Date:  2013-05       Impact factor: 6.126

5.  Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.

Authors:  Seth N Sclair; Ester Little; Cynthia Levy
Journal:  Clin Transl Gastroenterol       Date:  2015-08-27       Impact factor: 4.488

6.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.

Authors:  Willem J Lammers; Henk R van Buuren; Gideon M Hirschfield; Harry L A Janssen; Pietro Invernizzi; Andrew L Mason; Cyriel Y Ponsioen; Annarosa Floreani; Christophe Corpechot; Marlyn J Mayo; Pier M Battezzati; Albert Parés; Frederik Nevens; Andrew K Burroughs; Kris V Kowdley; Palak J Trivedi; Teru Kumagi; Angela Cheung; Ana Lleo; Mohamad H Imam; Kirsten Boonstra; Nora Cazzagon; Irene Franceschet; Raoul Poupon; Llorenç Caballeria; Giulia Pieri; Pushpjeet S Kanwar; Keith D Lindor; Bettina E Hansen
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

7.  Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

Authors:  Gideon M Hirschfield; Andrew Mason; Velimir Luketic; Keith Lindor; Stuart C Gordon; Marlyn Mayo; Kris V Kowdley; Catherine Vincent; Henry C Bodhenheimer; Albert Parés; Michael Trauner; Hanns-Ulrich Marschall; Luciano Adorini; Cathi Sciacca; Tessa Beecher-Jones; Erin Castelloe; Olaf Böhm; David Shapiro
Journal:  Gastroenterology       Date:  2014-12-11       Impact factor: 22.682
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.